K76.0
Conditions
Interventions
Group 1: Single arm pilotstudy.
Within this prospective, monocentric pilotstudy 80 patients with non-alcoholic fatty liver disease or steatohepatitis (NAFLD/NASH) will be recruited in the outpatient c
Sponsors
Goethe-Universität Frankfurt am Main
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of a non-alcoholic fatty liver disease
Exclusion criteria
Exclusion criteria: - Alcohol consumption = 20 g/d in female and = 30 g/d in male patients - Decompensated cirrhosis of the liver - Viral hepatitis - Non-viral primary or secondary liver diseases other than NAFLD/NASH - Malignancies (except for basalioma) within the last 5 years, in particular primary or secondary liver tumors - Orthotopic liver transplantation - Any comedication known to cause hepatic steatosis (i.e. steroids, Methotrexate, Amiodarone, Tamoxifen, Valproate, Flutamide, etc.) - Clinically relevant heart insufficiency, cardiac arrhythmias, relevant cardiac valve diseases - Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this pilot study is to establish an algorithm based on ultrasound raw data for the assessment of liver fibrosis and steatosis with methods of machine learning. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Germany
Contacts
Public ContactUlrike Mihm
Universitätsklinikum Frankfurt Medizinische Klinik 1
Outcome results
None listed